Alexis M Koskan1, Madeline Fernández-Pineda2. 1. 1 School of Nutrition and Health Promotion, College of Health Solutions, Arizona State University , Phoenix, Arizona. 2. 2 School of Nursing and Health Studies, University of Miami , Coral Gables, Florida.
Abstract
PURPOSE: This study explores HIV-positive gay and bisexual men's (GBM) understanding of human papillomavirus (HPV) and the HPV vaccine. METHODS: Researchers conducted 15 in-depth interviews with HIV-positive GBM between the ages of 18-30 years old. RESULTS: Two participants had received a single dose of the HPV vaccine. Otherwise, the majority of participants had either never heard of the HPV vaccine or they perceived it as a resource for women only. Other commonly cited barriers to getting the vaccine included lack of provider recommendation to complete the vaccine series and vaccine costs. CONCLUSIONS: Future provider-driven interventions should focus on increasing HPV vaccine among age-eligible HIV-positive GBM.
PURPOSE: This study explores HIV-positive gay and bisexual men's (GBM) understanding of human papillomavirus (HPV) and the HPV vaccine. METHODS: Researchers conducted 15 in-depth interviews with HIV-positive GBM between the ages of 18-30 years old. RESULTS: Two participants had received a single dose of the HPV vaccine. Otherwise, the majority of participants had either never heard of the HPV vaccine or they perceived it as a resource for women only. Other commonly cited barriers to getting the vaccine included lack of provider recommendation to complete the vaccine series and vaccine costs. CONCLUSIONS: Future provider-driven interventions should focus on increasing HPV vaccine among age-eligible HIV-positive GBM.
Authors: Alexandra L Hernandez; Jimmy T Efird; Elizabeth A Holly; J Michael Berry; Naomi Jay; Joel M Palefsky Journal: AIDS Date: 2014-06-01 Impact factor: 4.177
Authors: Mona Saraiya; Elizabeth R Unger; Trevor D Thompson; Charles F Lynch; Brenda Y Hernandez; Christopher W Lyu; Martin Steinau; Meg Watson; Edward J Wilkinson; Claudia Hopenhayn; Glenn Copeland; Wendy Cozen; Edward S Peters; Youjie Huang; Maria Sibug Saber; Sean Altekruse; Marc T Goodman Journal: J Natl Cancer Inst Date: 2015-04-29 Impact factor: 13.506
Authors: Helena Faust; Lars Toft; Peter Sehr; Martin Müller; Jesper Bonde; Ola Forslund; Lars Østergaard; Martin Tolstrup; Joakim Dillner Journal: Vaccine Date: 2016-02-16 Impact factor: 3.641
Authors: Sofie H Mooij; Fiona R M van der Klis; Marianne A B van der Sande; Rutger M Schepp; Arjen G C L Speksnijder; Johannes A Bogaards; Hester E de Melker; Henry J C de Vries; Peter J F Snijders; Maarten F Schim van der Loeff Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10 Impact factor: 4.254
Authors: Ashish A Deshmukh; Jagpreet Chhatwal; Elizabeth Y Chiao; Alan G Nyitray; Prajnan Das; Scott B Cantor Journal: Clin Infect Dis Date: 2015-07-29 Impact factor: 9.079
Authors: Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-03-27 Impact factor: 17.586
Authors: Mary A Gerend; Krystal Madkins; Shariell Crosby; Aaron K Korpak; Gregory L Phillips; Michael Bass; Magda Houlberg; Brian Mustanski Journal: LGBT Health Date: 2019-09-26 Impact factor: 4.151
Authors: Rulin C Hechter; Lei Qian; Sara Y Tartof; Lina S Sy; Nicola P Klein; Eric Weintraub; Cheryl Mercado; Allison Naleway; Huong Q McLean; Steven J Jacobsen Journal: Vaccine Date: 2019-05-04 Impact factor: 3.641